GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,936,000 | -0.9% | 44,473 | -0.9% | 0.14% | +15.8% |
| Q1 2022 | $1,954,000 | +1.1% | 44,860 | +2.4% | 0.12% | +0.8% |
| Q4 2021 | $1,933,000 | +20.9% | 43,829 | +5.1% | 0.12% | +19.0% |
| Q3 2021 | $1,599,000 | -1.8% | 41,696 | +2.0% | 0.10% | -12.3% |
| Q2 2021 | $1,628,000 | +32.6% | 40,883 | +19.5% | 0.11% | +21.3% |
| Q1 2021 | $1,228,000 | -6.1% | 34,213 | -3.8% | 0.09% | -14.5% |
| Q4 2020 | $1,308,000 | -7.4% | 35,553 | -5.3% | 0.11% | -17.3% |
| Q3 2020 | $1,413,000 | -4.2% | 37,531 | +2.5% | 0.13% | -15.3% |
| Q2 2020 | $1,475,000 | +20.0% | 36,601 | +13.1% | 0.16% | -12.3% |
| Q1 2020 | $1,229,000 | -32.8% | 32,375 | -17.1% | 0.18% | -2.7% |
| Q4 2019 | $1,828,000 | +7.7% | 39,065 | -1.8% | 0.18% | -1.6% |
| Q3 2019 | $1,698,000 | +8.9% | 39,786 | +2.1% | 0.19% | -5.6% |
| Q2 2019 | $1,559,000 | -3.8% | 38,976 | +0.2% | 0.20% | -10.0% |
| Q1 2019 | $1,620,000 | +4.0% | 38,900 | -4.2% | 0.22% | -10.2% |
| Q4 2018 | $1,557,000 | -14.5% | 40,589 | -10.9% | 0.24% | +9.9% |
| Q3 2018 | $1,822,000 | -1.0% | 45,580 | -0.9% | 0.22% | -10.1% |
| Q2 2018 | $1,840,000 | +1.7% | 46,010 | -0.7% | 0.25% | +3.8% |
| Q1 2018 | $1,810,000 | +56.4% | 46,323 | +43.0% | 0.24% | +56.2% |
| Q4 2017 | $1,157,000 | -30.7% | 32,396 | -21.9% | 0.15% | -36.5% |
| Q3 2017 | $1,669,000 | -12.1% | 41,501 | -4.9% | 0.24% | -23.5% |
| Q2 2017 | $1,898,000 | +1.6% | 43,659 | -1.7% | 0.32% | 0.0% |
| Q1 2017 | $1,869,000 | +6.9% | 44,431 | -1.5% | 0.32% | +9.4% |
| Q4 2016 | $1,748,000 | -8.2% | 45,116 | +3.0% | 0.29% | -9.4% |
| Q3 2016 | $1,904,000 | +4.8% | 43,800 | +5.1% | 0.32% | -0.3% |
| Q2 2016 | $1,816,000 | +42.8% | 41,659 | +31.9% | 0.32% | +38.7% |
| Q1 2016 | $1,272,000 | +14.5% | 31,578 | +14.0% | 0.23% | +13.3% |
| Q4 2015 | $1,111,000 | -2.3% | 27,697 | -6.1% | 0.20% | -3.3% |
| Q3 2015 | $1,137,000 | -25.0% | 29,489 | -19.2% | 0.21% | -15.0% |
| Q2 2015 | $1,516,000 | -28.6% | 36,510 | -20.6% | 0.25% | -30.2% |
| Q1 2015 | $2,123,000 | +10.9% | 45,965 | +2.2% | 0.35% | +9.3% |
| Q4 2014 | $1,914,000 | -2.9% | 44,982 | +5.0% | 0.32% | -3.3% |
| Q3 2014 | $1,971,000 | +80.8% | 42,840 | +110.0% | 0.34% | +82.1% |
| Q2 2014 | $1,090,000 | +2.9% | 20,403 | +3.0% | 0.18% | -31.3% |
| Q1 2014 | $1,059,000 | – | 19,816 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |